FDA Inspection 1166625 — John D. Gabriel, MD

John D. Gabriel, MD — FEI 3003947557

The FDA completed an inspection of John D. Gabriel, MD on March 25, 2022 in North Richland Hills, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 25, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
North Richland Hills, TX (United States)

Additional Details

Clinical Investigator (CI)